Abbott announced on 16 December that the US Food and Drug Administration has issued emergency use authorization for BinaxNOW COVID-19 Ag Card Home, its 'virtually guided' at-home COVID-19 antigen test. Users receive step-by-step instructions about the sample collection process and guidance in reading and understanding the results via an app.
Abbott said it will bring BinaxNOW to the patient’s home at a cost of $25 for testing and service via...